The latest call
FetchingOrchestra BioMed Holdings, Inc. reported on November 10, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$7.23+17.2%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 10, 2026
The quarter ending September 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $91K | $861K | -89.43% |
| Profit | -$18.8M | -$20.8M | +9.98% |
| Profit per share | -$0.30 | -$0.40 | +25.00% |
| Free Cash Flow | -$19.9M | -$14.9M | -34.16% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Orchestra BioMed Holdings, Inc. reported on November 10, 2026. We are fetching the call transcript; its summary follows once the transcript is in.